| PHARVARIS N.V. EO -,12 |
| Niederlande |
| Gesundheit |
| NL00150005Y4 / A2QNWS |
| 9EN (Frankfurt) / PHVS (NASDAQ) |
| FRA:9EN, ETR:9EN, 9EN:GR, NASDAQ:PHVS |
| - |
| https://pharvaris.com/ |
|
Pharvaris N.V. is a biopharmaceutical company that..
>Volltext.. |
| 1565.62 Mio. EUR |
| 1236.56 Mio. EUR |
| - |
| - |
| -155.74 Mio. EUR |
| -2.77 EUR |
| 0.59 Mio. EUR |
| 333.22 Mio. EUR |
| - |
| 12.56 |
| - |
| -19.61% |
| - |
| - |
| - |
| - |
| PHARVARIS |
| 03.12.25 |
|